GLP-1 Provider Price History (2026): Every Recorded Price Change and Correction, Dated

Every recorded change to a provider's price or to our record of it, newest first, with the old and new figures, the kind of change and the source. Price change means the provider changed its price; record corrected means our earlier figure, usually from a third-party source, was wrong or imprecise and has been replaced from the provider's own page; record changed (automatic) entries are written by the build whenever a recorded plan differs from the previous snapshot. This log is what lets the site say not only what a provider charges but when it changed.

Changes

• September 12, 2026 — Embody, tirzepatide and semaglutide: Listed pending from third-party citations ($119 flat, $129 promotional). New: recorded first-party from joinem.co — tirzepatide $129 one month (sale; regular $349), $378 / 3 months, $738 / 6 months, $1,428 / 12 months ($119/mo); semaglutide $79 (sale; regular $299), $228, $438, $828 ($69/mo); all payments final except on clinical ineligibility (refund policy 2026-08-25); operator Modern Metabolic Medicine, Inc. Now ranked. verified. Source: joinem.co collection and product pages, read 2026-09-05 to 09-12.
• September 12, 2026 — SnagRx, tirzepatide and semaglutide: Listed pending ($119 "locked for life" per one citation; $149 per another). New: recorded first-party from snagrx.com — $119/month tirzepatide (list $399) and $69/month semaglutide (list $299) under a "Fall Sale Discount Applied!" label; terms (2026-07-27) limit promotional pricing to the period stated at checkout; homepage countdown at 00:00:00:00 since 2026-09-11 with the price unchanged; cancel anytime month-to-month; all sales final; Louisiana excluded; same operator as Embody. Ranked with the promotional-rate flag. verified. Source: snagrx.com, read 2026-09-04 to 09-12.
• September 12, 2026 — Yucca Health, tirzepatide: Listed pending ($225 six-month / $258 month-to-month per citations). New: recorded first-party from tryyucca.com — $258 monthly, $744 / 3 months ($248), $1,350 / 6 months ($225) with an auto-applied lifetime lock on the six-month rate; flat at every dose; consultation, injection kit and 2-day shipping included; no 12-month plan; all sales final once the prescription is submitted (refund policy 2026-08-13, Brand Merchants Network LLC). Now ranked. verified. Source: tryyucca.com/tirzepatide/, read 2026-09-04 to 09-12.
• September 12, 2026 — Trimi, tirzepatide and semaglutide: Old: $125 annual (tirzepatide) and $99 annual (semaglutide) recorded as the only plans; an earlier note called the $235 month-to-month figure unsupported. New: full ladder printed on the plan page — tirzepatide $235 monthly, $597 quarterly ($199), $1,050 / 6 months ($175), $1,500 yearly ($125); semaglutide $175, $435 ($145), $720 ($120), $1,188 ($99); "medication + supplies, provider access, shipping included"; payment taken at checkout before provider review and refunded in full if not appropriate; stopping renewal does not end the current commitment (refund policy 2026-06-17). The earlier note is withdrawn. record corrected. Source: trytrimi.com plan pages, read 2026-09-11 and 09-12.
• September 12, 2026 — BMI MD, tirzepatide and semaglutide: Old: reported from a third-party directory (2026-08-19). New: month-to-month rows verified on bmimd.com — tirzepatide "as low as $179" (list $349.20), semaglutide $119 (list $228.60); $50 cancellation fee in the policy dated 2026-08-24; the homepage still carried a New Year's promotional banner. Multi-month tirzepatide rows keep their reported status. verified (month-to-month rows). Source: bmimd.com, read 2026-09-05 to 09-12.
• September 12, 2026 — NexLife, tirzepatide and semaglutide: Standard plans re-checked on 2026-09-04, 09-05, 09-09, 09-11 and 09-12 — $169 / $159 / $149 / $139 and $139 / $132 / $125 / $119, no change. Microdose tirzepatide moved from verified to reported: the program page's headline reads "$159 all-inclusive" (the September card announced 2026-08-31) while its plan tiles still print the prior card ($189 / $159 / $150 / $147); microdose semaglutide and the sublingual (ODT) rows are also reported (ODT program pages returned 404 on 2026-09-04 and 09-05). Cancellation: the FAQ (2026-09-09) describes plans as a cancel-anytime subscription; an earlier read recorded 30 days' notice. re-verified; status change on non-standard rows. Source: nexlife.us plan pages and FAQ.
• September 12, 2026 — All ranked providers: value scores recomputed after the field minimum moved from $1,500 (Trimi) to $1,428 (SnagRx, Embody) for tirzepatide and from $1,056 (Sunlight) to $828 (SnagRx, Embody) for semaglutide; 32 scores changed by one to four points, NexLife's from 92 to 91. Editor's pick unchanged (NexLife 91; SnagRx 90). recomputed (automatic). Source: automation/build_rankings.py, report automation/reports/rankings-2026-09-12.json.
• September 4, 2026 — All providers with a verified status: every verified plan price re-checked against the provider's own page; no price change recorded. NexLife plan pricing confirmed (tirzepatide $169 month-to-month, $159, $149, $139 on 3-, 6- and 12-month plans; semaglutide $139, $132, $125, $119). Reported and pending entries keep the date of their source. re-verified (no change). Source: provider pages.
• August 25, 2026 — Telos RX, tirzepatide: Injectable tirzepatide, continuing price. Old: $99 (third-party directory, checked 2026-08-05). New: about $139 long-plan floor; $99 was introductory. record corrected. Source: telosrx.com.
• August 25, 2026 — Sunlight, tirzepatide: Monthly price. Old: $239 (third-party directory, 2026-08-02). New: from $157 (starting price). record corrected. Source: sunlight.com.
• August 25, 2026 — Remedy Meds, tirzepatide: Recurring price. Old: $279 (recorded as flat). New: $279 first month, then $399. record corrected. Source: remedymeds.com.
• August 25, 2026 — Peak Wellness, tirzepatide: Lowest plan. Old: $229/mo twelve-month (third party, 2026-06-16). New: $232/mo six-month ($1,392); $279 first month then $349 monthly. record corrected. Source: go.trypeak.com.
• August 25, 2026 — Orderly Meds, tirzepatide: Recurring price. Old: unverified. New: $299/mo ($149 for two starter months); semaglutide $149. verified. Source: orderlymeds.com/pricing.
• August 25, 2026 — Oak (oaklovesyou.com), tirzepatide: Monthly price. Old: $185 (third-party directory, 2026-08-02). New: about $250 at checkout. record corrected. Source: checkout.oaklovesyou.com.
• August 25, 2026 — Mochi Health, tirzepatide: Medication price structure. Old: $90 to $199 'by dose' (answer-engine citation). New: $90 first month, then $199 at every dose; membership $39 then $79. record corrected. Source: joinmochi.com.
• August 25, 2026 — Ivím Health, tirzepatide: Pricing structure. Old: $133/mo + $74.99 membership. New: $1,100 per 6 months ($183.33/mo) or $900 per 4 months + $75 membership. record corrected. Source: ivimhealth.com/glp1-pricing.
• August 25, 2026 — Hims, semaglutide: Compounded semaglutide annual plan. Old: $165/mo. New: withdrawn; $39-then-$149 membership with medication billed separately. record corrected. Source: hims.com.
• August 25, 2026 — Henry Meds, tirzepatide: Injectable tirzepatide. Old: $179 (one source) / $449 (another). New: not listed on the program page; oral tirzepatide $349/mo. record corrected. Source: henrymeds.com/legal/programs (updated 2025-12-03).
• August 25, 2026 — GobyMeds, tirzepatide: Single-month price. Old: $349 (third-party directory, 2026-07-31). New: $299 any dose; $399 three-month starter; bundles $499–$599. record corrected. Source: gobymeds.com.
• August 25, 2026 — Fifty 410, tirzepatide: standard plan, 1-month term. Old: $299 start / n/a maintenance / intro $133 / membership none. New: $299 start / n/a maintenance / intro none / membership none. record changed (automatic). Source: database update at build.
• August 25, 2026 — Fella Health, tirzepatide: Compounded plan vs Zepbound-access service. Old: $149–$199 'by dose'. New: from $199/mo paid annually (compounded); $149/mo service excluding medication. record corrected. Source: fellahealth.com.
• December 22, 2025 — NovoCare Pharmacy (Wegovy), semaglutide: Oral Wegovy self-pay. New: $149 (1.5 mg / 4 mg through 2026-08-31), $299 (9 and 25 mg). price change. Source: NovoCare page; verified 2026-08-25.
• November 6, 2025 — NovoCare Pharmacy (Wegovy), semaglutide: Wegovy pens, self-pay initial fills. Old: $349. New: $199 initial fills, then $349. price change. Source: NovoCare page; verified 2026-08-25.
• November 6, 2025 — LillyDirect (Zepbound vials), tirzepatide: Zepbound vials (2.5 mg / 5 mg / 7.5–15 mg, Self Pay Journey). Old: $349 / $499 / $499. New: $299 / $399 / $449. price change. Source: Lilly coverage and savings page; verified 2026-08-25.
• March 10, 2025 — NovoCare Pharmacy (Wegovy), semaglutide: Wegovy pens, self-pay. Old: about $499. New: $349 flat. price change. Source: Novo Nordisk announcement.
• February 25, 2025 — LillyDirect (Zepbound vials), tirzepatide: Zepbound vials (2.5 mg / 5 mg; 7.5 and 10 mg added). Old: $399 / $549. New: $349 / $499; $499 higher doses. price change. Source: Eli Lilly announcement.
• August 27, 2024 — LillyDirect (Zepbound vials), tirzepatide: Zepbound vials (2.5 mg / 5 mg). New: $399 / $549. price change. Source: Eli Lilly announcement.

Reading the log

Most corrections in August 2026 moved figures from third-party directories toward what providers actually charge: introductory and starter prices had been recorded as continuing prices, service memberships as medication prices, and two products as one. The manufacturer entries are real price changes: Lilly cut Zepbound vial prices three times between August 2024 and November 2025, and Novo Nordisk cut Wegovy twice. Average verified compounded prices are tracked on the ranking pages; this page tracks movement.